JRCT ID: jRCT2080224944
Registered date:12/11/2019
Basic Information
Recruitment status | completed |
---|---|
Health condition(s) or Problem(s) studied | |
Date of first enrollment | 27/03/2020 |
Target sample size | 219 |
Countries of recruitment | Japan,North America,Europe |
Study type | Interventional |
Intervention(s) | investigational material(s) Generic name etc : INN of investigational material : - Therapeutic category code : 117 Psychotropic agents Dosage and Administration for Investigational material : control material(s) Generic name etc : INN of investigational material : - Therapeutic category code : --- Other Dosage and Administration for Investigational material : |
Outcome(s)
Primary Outcome | safety efficacy exploratory |
---|---|
Secondary Outcome | safety efficacy exploratory |
Key inclusion & exclusion criteria
Age minimum | >= 18age old |
---|---|
Age maximum | <= 55age old |
Gender | Both |
Include criteria | |
Exclude criteria |
Related Information
Primary Sponsor | |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) | NCT03745820,JapicCTI-195032 |
Contact
Public contact | |
Name | Biogen Japan Medical Information |
Address | Nihonbashi 1-chome Mitsui Building 14F, 1-4-1, Nihonbashi, Chuo-ku, Tokyo, 103-0027 |
Telephone | +81-120-560-086 |
japan-medinfo@biogen.com | |
Affiliation | Biogen Japan Ltd. |
Scientific contact | |
Name | Hiroshi Tsuda |
Address | Nihonbashi 1-chome Mitsui Building 14F, 1-4-1, Nihonbashi, Chuo-ku, Tokyo, 103-0027 |
Telephone | +81-120-560-086 |
japan-medinfo@biogen.com | |
Affiliation | Biogen Japan Ltd. |